FDA Acknowledges Letter to DePaul University

The FDA has issued a notice acknowledging a letter received from DePaul University's Idea Realization Laboratory. The document, an attachment to the regulations.gov filing, is an acknowledgment letter from the FDA's Center for Devices and Radiological Health (CDRH) to DePaul University.

This notice is informational and does not impose new requirements or obligations on regulated entities. Compliance officers should note that this is a procedural acknowledgment and does not contain substantive regulatory guidance or changes. No specific actions are required from regulated entities based on this filing.